Taking a longer term view of cardiovascular risk: the causal exposure paradigm

BMJ. 2014 May 21:348:g3047. doi: 10.1136/bmj.g3047.
No abstract available

MeSH terms

  • Age Factors
  • Cardiovascular Diseases / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Risk Assessment
  • Risk Factors

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors